PolyBatics
PolyBatics biobeads are based on the natural ability of bacteria to produce bioplastic particles. Combining this natural process with the tools of molecular biology, PolyBatics is able to produce lower toxicity, multi-funcionality biobeads in a single, efficient step. Multiple functions can be engineered onto the beads enabling complex chemical reactions, or capture and reporter molecules for use in diagnostics.
Support Provided to Date
Investment raising, Business Management Acquisition, Board Assignments
Investors: MIG, Sparkbox, GD1
Founding Team:
Dr Bernd Rehm, CTO
Bernd’s research focuses on microbial biosynthesis of polymers and biosurfactants as well as on the self-organisation of biological nanostructures produced by microorganisms. The biosynthesis of alginates, polyhydroxyalkanoates (bioplastics, biopolyester) and rhamnolipids and the formation of intracellular polymer and protein self-assemblies are investigated. These studies involve synthetic biology approaches and the application of a broad spectrum of imaging techniques as well as a variety of analytical methods.
Tracy Thompson, CEO
The founding CEO, Tracy has raised NZ$5.2M for the development and commercialization of a platform manufacturing technology. Prior to joining PolyBatics, Tracy was the senior investments manager for Plant & Food Research. A California native, Tracy was Business Development Manager for Agilent Technologies, Director of Business Development for Affymetrix and COO, VP Business Development for Polymer Technology Systems, Inc.
www.polybatics.com